ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.

Yihua Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.